Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the incidence of contrast-induced nephropathy (CIN)
following the administration of iopamidol-370 (Iopamiro-370) and iodixanol-320 (Visipaque
320) in patients with chronic kidney disease undergoing coronary angiography.
Phase:
Phase 4
Details
Lead Sponsor:
Guangdong General Hospital Guangdong Provincial People's Hospital
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University Guangzhou General Hospital of Guangzhou Military Command Nanfang Hospital of Southern Medical University Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University